CopyMark Law Group
4.9/5
Drawing for SALUBRISBIO

USPTO serial 99177965

SALUBRISBIO

Reviewed by CopyMark Law Group

Reg. 8067359Status 700Registered
Filing date
Status date
Registration date
Dec 16, 2025
Examiner
HANNAH, JESSICA L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SALUBRISBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES, LLC1540 W. Warm Springs RoadSuite 100Henderson, NV 89014

Goods and services

ClassDescriptionStatusFirst use
005Anti-diabetic pharmaceuticals; Injectable dermal filler; Enzymes for medical purposes; Insulin; Vaccines for human use; Diagnostic preparations for medical purposes; Dietetic foods adapted for medical use; Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biological preparations for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biologics in the nature of cells for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 31, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 31, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 16, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 16, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2025DOCKASSIGNED TO EXAMINER—
Sep 19, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 9, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance